Studies from Chinese University of Hong Kong Yield New Information about Pancreatic Cancer (Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment)

Media coverage

• Title	Studies from Chinese University of Hong Kong Yield New Information about Pancreatic Cancer (Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment)
  Media name/outlet	Daily Hong Kong Report
  Country/Territory	United States
  Date	27/07/26
  Persons	HOI YEE TONG